The directors are responsible for the preparation, integrity and
fair presentation of the financial statements of Aspen Pharmacare
Holdings Ltd and its subsidiaries.
The directors consider that in preparing the financial statements
they have used the most appropriate accounting policies,
consistently applied and supported by reasonable and prudent
judgements and estimates, and that all International Financial
Reporting Standards that they consider to be applicable have been
followed. The directors are satisfied that the information contained
in the financial statements fairly presents the consolidated and
separate financial position of Aspen Pharmacare Holdings Ltd
at 30 June 2009, and its consolidated and separate financial
performance and its consolidated and separate cash flows for the
year then ended. The directors also prepared the other information
included in the annual report and are responsible for both its
accuracy and its consistency with the financial statements.
The directors have responsibility for ensuring that accounting
records are kept. The accounting records should disclose with
reasonable accuracy the financial position of the Group to enable
the directors to ensure that the financial statements comply with
the relevant legislation.
The preparation of financial statements in conformity with
International Financial Reporting Standards requires management
to make estimates and assumptions that affect the reported
amounts of assets and liabilities at the date of the financial
statements and the reported expenses during the reporting
period. Actual results could differ from those estimates.
Aspen Pharmacare Holdings Ltd and its subsidiaries operated in a
well-established control environment, which is well documented
and regularly reviewed. This incorporates risk management and
internal control procedures, which are designed to provide reasonable, but not absolute, assurance that assets are safeguarded
and the risks facing the business are being controlled.
The going-concern basis has been adopted in preparing the
financial statements. The directors have no reason to believe that
the Group or any company within the Group will not be going
concerns in the foreseeable future, based on forecasts, available
cash resources and available banking facilities. These financial
statements support the viability of the Company and the Group.
The Code of Corporate Practices and Conduct has been adhered
The Group’s external auditors, PricewaterhouseCoopers Inc.,
audited the financial statements, and their report is presented here.
The financial statements were approved by the Board of Directors
on 22 October 2009 and are signed on its behalf:
Dr Judy Dlamini
Deputy Group Chief Executive
22 October 2009